Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 2/3 × Anxiety Disorders × Melatonin × Clear all

Phase

Status

Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Conditions

Neoplasms 3 Fatigue 2 Depression 2 Breast Neoplasms 2 Anxiety Disorders 2 Parasomnias 1 Pain 1

Interventions

Oxygen 2 Melatonin 2 Ultraviolet Therapy 1 Surveys and Questionnaires 1 Mindfulness-Based Stress Reduction 1 Methylphenidate 1 Cognitive Behavioral Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05474846 2025-11-06

Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer

M.D. Anderson Cancer Center

Phase 2/3 Recruiting

Anxiety Disorders, Depression, Fatigue, Neoplasms

NCT01355523 2014-05-06

MELODY

Herlev Hospital

Phase 2/3 Terminated

54 enrolled 27 charts

Anxiety Disorders, Breast Neoplasms, Depression, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡